Involvement of the Fas (CD95) system in peripheral cell death and lymphoid organ development

European Journal of Immunology

Volumn 28, Issue 3, 1998, Pages 1078-1088

  Laouar, Yasmina ^a   Sarukhan, Adelaida ^a   Pasqualetto, Valérie ^a   Garcia, Corinne ^a   Ezine, Sophie ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Fas Fas ligand interaction; T cell

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD95; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL DEATH; CHIMERA; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; FAS LIGAND PROTEIN; LYMPH NODES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0031881260     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199803)28:03<1078::AID-IMMU1078>3.0.CO;2-T     Document Type: Article

References (61)

1. Cohen, P. L. and Eisenberg, R. A., Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991. 9: 243-266.
2. Roths, J. B., Murphy, E. D. and Eicher, E. M., A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 1984. 159: 1-20.
3. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
4. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
5. Allen, R. D., Marshall, J. D., Roths, J. B. and Sidman, C. L., Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 1990. 172: 1367-1375.
6. Chu, J. L., Drappa, J., Parnassa, A. and Elkon, K. B., The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 1993. 178: 723-730.
7. Adachi, M., Watanabe-Fukunaga, R. and Nagata, S., Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 1993. 90: 1756-1760.
8. Wu, J., Zhou, T., He, J. and Mountz, J. D., Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 1993. 178: 461-468.
9. Brunner, T., Mogil, R. J., Laface, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Et, A. L., Cellautonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
10. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
11. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
12. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N. and Nagata, S., Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 1996. 93: 2131-2136.
13. Giese, T. and Davidson, W. F., Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J. Immunol. 1992. 149: 3097-3106.
14. Herron, L. R., Eisenberg, R. A., Roper, E., Kakkanaiah, V. N., Cohen, P. L. and Kotzin, B. L., Selection of the T cell receptor repertoire in Lpr mice. J. Immunol. 1993. 151: 3450-3459.
15. Kotzin, B. L., Babcock, S. K. and Herron, L. R., Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2-T cells of lpr mice. J. Exp. Med. 1988. 168: 2221-2229.
16. Mountz, J. D., Smith, T. M. and Toth, K. S., Altered expression of self-reactive T cell receptor Vβ regions in autoimmune mice. J. Immunol. 1990. 144: 2159-2166.
17. Musette, P., Pannetier, C., Gachelin, G. and Kourilsky, P., The expansion of a CD4+ T cell population bearing a distinctive β chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection. Eur. J. Immunol. 1994. 24: 2761-2766.
18. Sidman, C. L., Marshall, J. D. and Von Boehmer, H., Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur. J. Immunol. 1992. 22: 499-504.
19. Singer, G. G. and Abbas, A. K., The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994. 1: 365-371.
20. Singer, G. G., Carrera, A. C., Marshak-Rothstein, A., Martinez, C. and Abbas, A. K., Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 1994. 6: 913-920.
21. Singer, P. A., Balderas, R. S., McEvilly, R. J., Bobardt, M. and Theofilopoulos, A. N., Tolerance-related Vβ clonal deletions in normal CD4-8-, TCR-α/β+ and abnormal lpr and gld cell populations. J. Exp. Med. 1989. 170: 1869-1877.
22. Sytwu, H. K., Liblau, R. S. and McDevitt, H. O., The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 17-30.
23. Nishimura, Y., Ishii, A., Kobayashi, Y., Yamasaki, Y. and Yonehara, S., Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 1995. 154: 4395-4403.
24. Andjelic, S., Drappa, J., Lacy, E., Elkon, K. B. and Nikolic-Zugic, J., The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult αβ thymocytes. Int. Immunol. 1994. 6: 73-79.
25. Lynch, D. H., Ramsdell, F. and Alderson, M. R., Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 1995. 16: 569-574.
26. Wu, J., Zhou, T., Zhang, J., He, J., Gause, W. C. and Mountz, J. D., Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic. MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA 1994. 91: 2344-2348.
27. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M., Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995. 81: 935-946.
28. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, A. G., Debatin, K. M., Fischer, A. and de Villartay, J.-P., Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995. 268: 1347-1349.
29. Bettinardi, A. Brugnoni, D., Quirós-Roldan, E., Malagoli, A., La Grutta, S., Correra, A. and Notarangelo, L. D., Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 1997. 8: 902-909.
30. Ettinger, R., Wang, J. K., Bossu, P., Papas, K., Sidman, C. L., Abbas, A. K. and Marshak-Rothstein, A., Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect. J. Immunol. 1994. 152: 1557-1568.
31. Theofilopoulos, A. N., Balderas, R. S., Gozes, Y., Aguado, M. T., Hang, L. M., Morrow, P. R. and Dixon, F. J., Association of lpr gene with graft-vs-host disease-like syndrome. J. Exp. Med. 1985. 162: 1-18.
32. Rappaport, H., Khalil, A., Halle-Pannenko, O., Pritchard, L., Dantchev, D. and Mathe, G., Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers. Am. J. Pathol. 1979. 96: 121-142.
33. Fujiwara, M. and Kariyone, A., One-way occurrence of graft-versus-host disease in bone marrow chimaeras between congenic MRL mice. Immunology 1984. 53: 251-256.
34. Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S., Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 1995. 14: 12-18.
35. Chu, J. L., Ramos, P., Rosendorff, A., Nikolic-Zugic, J., Lacy, E., Matsuzawa, A. and Elkon, K. B., Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 1995. 181: 393-398.
36. Bosma, G. C., Custer, R. P. and Bosma, M. J., A severe combined immunodeficiency mutation in the mouse. Nature 1983. 301: 527-530.
37. Mosier, D. E., Gulizia, R. J., Baird, S. M. and Wilson, D. B., Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988. 335: 256-259.
38. McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M. and Weissman, I. L., The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988. 241: 1632-1639.
39. Rocha, B., Dautigny, N. and Pereira, P., Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immunol. 1989. 19: 905-911.
40. Perkins, D. L., Michaelson, J., Glaser, R. M. and Marshak-Rothstein, A., Selective elimination of non-lpr lympoid cells in mice undergoing lpr-mediated graft-vs-host disease. J. Immunol. 1987. 139: 1406-1413.
41. Papiernik, M., Leite de Moraes, M. C., Pontoux, C., Joret, A.-M., Rocha, B., Penit, C. and Dy, M., T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J. Immunol. 1987. 158: 4642-4653.
42. Papiernik, M., Leite de Moraes, M., Pontoux, C., Vasseur, F. and Penit, C., Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion, and IL-2 dependency. Int. Immunol. 1998 (in press).
43. Miyashima, S., Nagata, N., Nakagawa, T., Hosaka, N., Takeuchi, K., Ogawa, R. and Ikehara, S., Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. J. Immunol. 1996. 156: 79-84.
44. Akbar, A. N. and Salmon, M., Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol. Today 1997. 18: 72-76.
45. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
46. Tucek-Szabo, C. I., Andjelic, S., Lacy, E., Elkon, K. B. and Nikolic-Zugic, J., Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. J. Immunol. 1996. 156: 192-200.
47. Lowin, B., Mattman, C., Hahne, M. and Tschopp, J., Comparison of Fas(Apo-1/CD95)-and perforin-mediated cytotoxicity in primary T lymphocytes. Int. Immunol. 1996. 8: 57-63.
48. Budd, R. C., Cerottini, J. C., Horvath, C., Bron, C., Pedrazzini, T., Howe, R. C. and MacDonald, H. R., Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 1987. 138: 3120-3129.
49. Lee, W. T. and Vitetta, E. S., The differential expression of homing and adhesion molecules on virgin and memory T cells in the mouse. Cell. Immunol. 1991. 132: 215-222.
50. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S., Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995. 154: 3806-3813.
51. Sobel, E. S., Yokoyama, W. M., Shevach, E. M., Eisenberg, R. A. and Cohen, P. L., Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes. J. Immunol. 1993. 150: 673-682.
52. Suda, T., Tanaka, M., Miwa, K. and Nagata, S., Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol. 1996. 157: 3918-3924.
53. Renno, T., Hahne, M., Tschopp, J. and MacDonald, H. R., Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 1996. 183: 431-437.
54. Huang, L., Soldevila, G., Leeker, M., Flavell, R. and Crispe, I. N., The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994. 1: 741-749.
55. Aurrand-Lions, M., Galland, F., Bazin, H., Zakharyev, V. M., Imhof, B. A. and Naquet, P., Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing. Immunity 1996. 5: 391-405.
56. Rennert, P. D., Browning, J. L., Mebius, R., MacKay, F. and Hochman, P. S., Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 1996. 184: 1999-2006.
57. Kosco-Vilbois, M. H., Zentgraf, H., Gerdes, J. and Bonnefoy, J. Y., To 'B' or not to 'B' a germinal center? Immunol. Today 1997. 18: 225-230.
58. Penit, C. and Vasseur, F., Phenotype analysis of cycling and postcycling thymocytes: evaluation of detection methods for BrdUrd and surface proteins. Cytometry 1993. 14: 757-763.
59. Rouvier, E. Luciani, M. F. and Golstein, P., Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993. 177: 195-200.
60. Golstein, P., Marguet, D. and Depraetere, V., Fas bridging cell death and cytotoxicity: the reaper connection. Immunol. Rev. 1995. 146: 45-56.
61. Matzinger, P., The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 1991. 145: 185-192.